MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Xenon Pharmaceuticals Inc

XENE

#1349
Xenon Pharmaceuticals Inc
43.2300
-2.43%
Sector:
Base:
Profit Currency:
Daily Range
43.2300
43.2500
Year Range
37.2300
46.5600
Daily Change
-2.43%
Monthly Change
+1.98%
6 month change
+5.98%
Year Change
+5.98%
Previous Close
44.3050
Open
43.2500
Bid
Ask
Low
43.2300
High
43.2500
Volume
189
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. XENE
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

News

Seeking Alpha Seeking Alpha
BABA CRWD AVGO RIOT CORZ
yesterday, 16:00
Alibaba Earnings, Jobs Data
Investing Investing
XENE
2 days ago, 14:53
Xenon Pharmaceuticals stock hits 52-week high at $46.68
Zacks Zacks
NBIX USNA XENE RXRX
2 days ago, 14:37
Xenon Q4 Loss Wider Than Expected, Pipeline Development in Focus
Investing Investing
XENE
2026.02.25
Xenon earnings loom as investors brace for Phase 3 catalyst
Investing Investing
XENE
2026.02.24
Wolfe Research initiates Xenon Pharmaceuticals stock coverage with outperform rating
Investor's Business Daily Investor's Business Daily
XENE INVA ARGX AUPH
2026.02.24
Xenon Pharmaceuticals Stock Scores RS Rating Upgrade
Investing Investing
XENE
2026.02.09
Stifel raises Xenon Pharmaceuticals stock price target to $66 on XEN1101 potential
Investing Investing
XENE BHVN
2026.01.21
Biohaven stock rating upgraded by RBC Capital on promising CNS data
Seeking Alpha Seeking Alpha
XENE
2026.01.12
Xenon Pharmaceuticals Inc. (XENE) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:XENE) 2026-01-12
Seeking Alpha Seeking Alpha
XENE
2026.01.12
Xenon Pharmaceuticals Inc. (XENE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Investing Investing
XENE
2026.01.12
Xenon’s azetukalner Phase 3 data for epilepsy expected in March
Investing Investing
XENE
2026.01.09
JPMorgan reiterates Overweight rating on Xenon Pharmaceuticals stock

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd